Effectiveness of treatment of patients with systemic autoimmune diseases on the background of reactivation of persistent Epstein-Barr virus infection

QR Code

Effectiveness of treatment of patients with systemic autoimmune diseases on the background of reactivation of persistent Epstein-Barr virus infection

The article presents the study of effectiveness of inosine pranobex (IP) in patients with systemic autoimmune diseases (SAD) on the background of reactivation of persistent Epstein-Barr (EBV) infection. Among 380 patients with SAD (systemic lupus erythematosus, systemic vasculitides, rheumatoid art...

Full description

Saved in:

Bibliographic Details
Main Authors:	K.O. Lishchuk-Yakymovych, I.H. Haiduchok, K.E. Ischeykin, V.V. Chopyak
Format:	Article
Language:	English
Published:	Dnipro State Medical University 2021-09-01
Series:	Medičnì Perspektivi
Subjects:	systemic autoimmune diseases Epstein-Barr virus antiviral therapy
Online Access:	https://journals.uran.ua/index.php/2307-0404/article/view/241936
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Role of Epstein-Barr Virus in the Pathogenesis of Autoimmune Diseases
by: Natalia Morawiec, et al.
Published: (2025-06-01)

Epstein–Barr virus and mechanisms of molecular carcinogenesis
by: A. D. Molchanov, et al.
Published: (2025-06-01)

Recent Progress in the Vaccine Development Against Epstein–Barr Virus
by: Yihao Dai, et al.
Published: (2025-06-01)

Pathological features of the central nervous system lesions with Epstein-Barr virus in patients with HIV/AIDS
by: Kozko V.N., et al.
Published: (2013-12-01)

serologic markers of Epstein-Barr virus reactivation in the conditions of viral encephalitis in young patients
by: O. V. Goleva, et al.
Published: (2015-04-01)

Seasonality of infection caused by Epstein – Barr virus
by: T. V. Solomay, et al.
Published: (2020-10-01)

Epstein-Barr Virus-associated Gastric Carcinoma
by: Bong Eun Lee
Published: (2021-03-01)

Variants of Epstein—Barr viral infection course in infectious mononucleosis nidus for the children
by: A. P. Pomogaeva, et al.
Published: (2003-06-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

CLINICAL-IMMUNOLOGY EFFICIENCY OF CONSERVATIVE TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS ASSOCIATED WITH EPSTEIN - BARR VIRUS INFECTION
by: A. S. Krasnitskaja, et al.
Published: (2012-05-01)

A case of Epstein Barr virus-associated primary squamous cell carcinoma of stomach
by: Yuki Katsura, et al.
Published: (2021-11-01)

EFFICACY OF RIBOSOMAL COMPLEX IN EPSTEIN–BARR VIRAL INFECTION IN CHILDREN
by: S.N. Orlova, et al.
Published: (2011-11-01)

HUMORAL IMMUNE RESPONSES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH PRECANCEROUS GASTRIC LESIONS AND GASTRIC CANCER OF DIFFERENT HISTOTYPES
by: M. V. Vusik, et al.
Published: (2016-11-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

IN VITRO CELLULAR RESPONSE TO INTERFERON-α2 IN CHILDREN WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN-BARR VIRUS
by: L. M. Kurtasova, et al.
Published: (2016-04-01)

Epstein-Barr virus in Adygeans and Slavs in Russia: virus types, <i>LMP1</i> variants, and malignant tumors
by: K. V. Smirnova, et al.
Published: (2022-10-01)

CONTENTS OF IL-1Β, IL-RA, IL-4, IL-8 AND IFNΓ IN THE CHILDREN WITH MINOR CLINICAL FORMS OF TUBERCULOSIS INFECTED WITH TOXOPLASMA GONDII AND EPSTEIN–BARR VIRUS
by: A. V. Kalityn, et al.
Published: (2014-07-01)

Histopathological characteristics of Epstein-Barr virus (EBV)–associated encephalitis and colitis in chronic active EBV infection
by: Betty A Kasimo, et al.
Published: (2025-05-01)

The growing interests in Epstein–Barr virus: A bibliometric analysis of research trends, collaborations, and emerging hotspots
by: Lu Li, et al.
Published: (2025-09-01)

Markers of Epstein–Barr virus in clinical assessment of Russian patients with nasopharyngeal cancer
by: K. V. Smirnova, et al.
Published: (2021-11-01)

Comparison between ELISA and PCR for Detection of Epstein - Barr virus in children with acute cervical lymphadenitis
by: Nazim Khan, et al.
Published: (2024-11-01)

Association and Interaction of Epstein–Barr Virus with SARS-CoV-2 Infection—A Review
by: Supriya Mahajan, et al.
Published: (2025-06-01)

About features clinical acute Epstein-Barr virus infection in children syndrome undifferentiated Connective tissue dysplasia
by: S. N. Orlova, et al.
Published: (2014-09-01)

INFLUENCE OF CYCLOFERON ON THE CELLULAR SUSCEPTIBILITY TO INTERFERON-α2 IN VITRO IN PATIENTS WITH INFECTIOUS MONONUCLEOSIS CAUSED BY EPSTEIN– BARR VIRUS
by: L. M. Kurtasova, et al.
Published: (2018-12-01)

Retrospective Review of Children Hospitalized for Epstein–Barr Virus-Related Infectious Mononucleosis
by: Shufeng Tian, et al.
Published: (2025-07-01)

Auto-Immune Glial Fibrillary Acidic Protein Astrocytopathy with Active Intrathecal Epstein-Barr Virus: A Single-Center Case Series Report
by: Yu X, et al.
Published: (2025-05-01)

Toll-like Receptor 9 Mediates Epstein–Barr Virus-Aggravated Inflammation in a Mouse Model of Inflammatory Bowel Disease
by: Hassan F. Nour Eddine, et al.
Published: (2025-06-01)

The persistence of Epstein-Barr virus in the gastric mucosa in patients with chronic <i>Helicobacter pylori</i>-induced gastritis with gastric erosions and the effect on the course of the disease depending on the therapy
by: E. E. Dubskaya, et al.
Published: (2021-11-01)

INFLAMMATORY INFILTRATION IN THE GASTRIC MUCOSA OF PATIENTS WITH EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC DYSPLASIA AND CANCER
by: М. V. Vusik, et al.
Published: (2016-02-01)

Molecular profile of Epstein–Barr virus in representatives of four ethnic groups of Russia: virus types, <i>LMP1</i> gene variability and malignancies
by: K. V. Smirnova, et al.
Published: (2023-12-01)

Epstein–Barr viral infection in children: clinical characteristic, modern aspects of diagnostics, differentiated approach to treatment
by: L. M. Panasenko, et al.
Published: (2021-06-01)

Distribution and Clinical Impact of <i>Helicobacter pylori</i> Virulence Factors in Epstein–Barr-Virus-Associated Gastric Cancer
by: Jin Hee Noh, et al.
Published: (2025-06-01)

The role of cycloferon in the treatment of chronic Helicobacter pyloriinduced gastritis with gastric erosions associated with Epstein – Barr virus
by: T. E. Afanasenkova, et al.
Published: (2022-02-01)

CRISPR/Cas13-Mediated Inhibition of EBNA1 for Suppression of Epstein–Barr Virus Transcripts and DNA Load in Nasopharyngeal Carcinoma Cells
by: Lin Lin, et al.
Published: (2025-06-01)

Pathogenesis of formation of frequent respiratory infections in children with Epstein-Barr virus and cytomegalovirus infection
by: I. V. Babachenko, et al.
Published: (2014-09-01)

The clinical and laboratory characteristics of infectious mononucleosis caused by the Epstein-Barr virus type 1 in hospitalized children
by: M. I. Popkova, et al.
Published: (2023-04-01)

Oral hairy leukoplakia: The role of Epstein–Barr virus, the occurrence in immunocompetent patients, and the malignant transformation potential
by: Yu-Hsueh Wu, et al.
Published: (2025-07-01)

Analysis of risk factors for Epstein–Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
by: Lanzhou Jia, et al.
Published: (2025-07-01)

Diagnostic value of Epstein – Barr virus DNA quantification in blood leukocytes in children with infectious mononucleosis
by: M. I. Popkova, et al.
Published: (2022-07-01)

Stromal Herpetic Keratitis with Ulceration Associated with Reactivation of Epstein–Barr Virus and Human Herpes Virus Type 6: Experience of Diagnosis and Therapy
by: G. M. Chernakova, et al.
Published: (2022-10-01)